tiprankstipranks
Trending News
More News >
PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market
Advertisement

PTC Therapeutics (PTCT) Ratios

Compare
401 Followers

PTC Therapeutics Ratios

PTCT's free cash flow for Q3 2025 was $0.93. For the 2025 fiscal year, PTCT's free cash flow was decreased by $ and operating cash flow was $0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.32 2.02 1.71 1.52 4.44
Quick Ratio
2.26 1.97 1.65 1.49 4.37
Cash Ratio
0.78 0.98 1.01 1.52 0.75
Solvency Ratio
0.28 -0.14 -0.21 -0.23 -0.23
Operating Cash Flow Ratio
0.83 -0.26 -0.88 -0.49 -0.70
Short-Term Operating Cash Flow Coverage
2.38 -0.82 -28.83 -1.57 -22.20
Net Current Asset Value
$ -791.65M$ -1.50B$ -1.36B$ -1.16B$ -494.55M
Leverage Ratios
Debt-to-Assets Ratio
0.16 1.18 0.41 0.22 0.19
Debt-to-Equity Ratio
-2.63 -2.72 -2.03 300.02 0.87
Debt-to-Capital Ratio
1.61 1.58 1.97 1.00 0.47
Long-Term Debt-to-Capital Ratio
-2.35 1.75 2.55 0.99 0.39
Financial Leverage Ratio
-16.97 -2.32 -4.91 1.35K 4.58
Debt Service Coverage Ratio
2.07 -0.81 -3.29 -1.55 -5.10
Interest Coverage Ratio
5.62 -2.70 -4.84 -4.36 -7.06
Debt to Market Cap
0.07 1.02 0.21 0.16 0.08
Interest Debt Per Share
6.99 31.51 11.08 7.34 7.22
Net Debt to EBITDA
-0.29 -4.95 -0.80 0.91 -0.71
Profitability Margins
Gross Profit Margin
99.66%93.02%93.61%94.00%95.03%
EBIT Margin
49.41%-60.45%-71.07%-80.27%-91.02%
EBITDA Margin
50.57%-35.22%-52.63%-69.52%-78.00%
Operating Profit Margin
43.61%-37.26%-62.95%-69.62%-104.49%
Pretax Profit Margin
41.65%-74.23%-84.07%-96.24%-105.82%
Net Profit Margin
42.25%-66.81%-80.00%-97.27%-115.07%
Continuous Operations Profit Margin
42.25%-66.81%-80.00%-97.27%-115.07%
Net Income Per EBT
101.45%90.02%95.15%101.07%108.74%
EBT Per EBIT
95.50%199.23%133.54%138.25%101.27%
Return on Assets (ROA)
28.43%-33.05%-32.78%-27.03%-19.84%
Return on Equity (ROE)
-182.66%76.55%161.06%-36432.61%-90.91%
Return on Capital Employed (ROCE)
43.65%-27.03%-33.86%-26.24%-20.61%
Return on Invested Capital (ROIC)
37.87%-20.93%-31.61%-23.70%-22.21%
Return on Tangible Assets
34.72%-43.70%-60.94%-46.33%-31.06%
Earnings Yield
12.98%-30.38%-20.42%-18.67%-10.87%
Efficiency Ratios
Receivables Turnover
8.76 5.82 4.49 4.88 5.45
Payables Turnover
0.00 10.83 1.64 1.40 1.01
Inventory Turnover
0.11 2.14 2.05 2.04 1.01
Fixed Asset Turnover
12.92 5.24 3.99 4.14 3.22
Asset Turnover
0.67 0.49 0.41 0.28 0.17
Working Capital Turnover Ratio
1.28 2.08 2.53 0.88 0.51
Cash Conversion Cycle
3.24K 199.40 36.67 -6.18 67.65
Days of Sales Outstanding
41.66 62.67 81.28 74.85 67.03
Days of Inventory Outstanding
3.20K 170.43 178.16 179.02 360.28
Days of Payables Outstanding
0.00 33.69 222.77 260.05 359.66
Operating Cycle
3.24K 233.10 259.44 253.88 427.31
Cash Flow Ratios
Operating Cash Flow Per Share
9.12 -2.12 -4.97 -3.57 -2.94
Free Cash Flow Per Share
8.95 -3.73 -7.10 -4.78 -3.79
CapEx Per Share
0.17 1.61 2.13 1.21 0.85
Free Cash Flow to Operating Cash Flow
0.98 1.76 1.43 1.34 1.29
Dividend Paid and CapEx Coverage Ratio
55.11 -1.31 -2.34 -2.95 -3.47
Capital Expenditure Coverage Ratio
55.11 -1.31 -2.34 -2.95 -3.47
Operating Cash Flow Coverage Ratio
1.74 -0.07 -0.51 -0.58 -0.46
Operating Cash Flow to Sales Ratio
0.40 -0.17 -0.51 -0.47 -0.51
Free Cash Flow Yield
11.85%-13.53%-18.60%-12.00%-6.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
7.69 -3.29 -4.90 -5.36 -9.20
Price-to-Sales (P/S) Ratio
3.33 2.20 3.92 5.21 10.58
Price-to-Book (P/B) Ratio
-37.13 -2.52 -7.89 1.95K 8.36
Price-to-Free Cash Flow (P/FCF) Ratio
8.42 -7.39 -5.38 -8.34 -16.12
Price-to-Operating Cash Flow Ratio
8.08 -13.02 -7.68 -11.17 -20.76
Price-to-Earnings Growth (PEG) Ratio
0.39 -0.44 -1.01 -0.45 -0.17
Price-to-Fair Value
-37.13 -2.52 -7.89 1.95K 8.36
Enterprise Value Multiple
6.28 -11.19 -8.24 -6.58 -14.28
Enterprise Value
5.66B 3.70B 3.03B 2.46B 4.24B
EV to EBITDA
6.30 -11.19 -8.24 -6.58 -14.28
EV to Sales
3.18 3.94 4.34 4.58 11.14
EV to Free Cash Flow
8.06 -13.25 -5.95 -7.32 -16.96
EV to Operating Cash Flow
7.92 -23.34 -8.50 -9.81 -21.85
Tangible Book Value Per Share
-8.09 -17.11 -15.83 -11.43 -4.78
Shareholders’ Equity Per Share
-1.98 -10.94 -4.84 0.02 7.30
Tax and Other Ratios
Effective Tax Rate
-0.01 0.10 0.05 -0.01 -0.09
Revenue Per Share
22.67 12.53 9.74 7.64 5.77
Net Income Per Share
9.58 -8.37 -7.79 -7.43 -6.64
Tax Burden
1.01 0.90 0.95 1.01 1.09
Interest Burden
0.84 1.23 1.18 1.20 1.16
Research & Development to Revenue
0.25 0.71 0.93 1.00 1.25
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.04 0.14 0.16 0.19 0.18
Income Quality
0.95 0.25 0.64 0.48 0.44
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis